On the public citation graph

Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes

0 signed · 478 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1096-9136(199804)15:4<297::aid-dia572>3.0.co;2-wopenalex-snapshot
UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years
inferredcites →https://doi.org/10.1007/978-1-4757-9613-1_15openalex-snapshot
Structure of CD26 (Dipeptidyl Peptidase IV) and Function in Human T Cell Activation
inferredcites →https://doi.org/10.1007/s00125-005-1707-5openalex-snapshot
Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes
inferredcites →https://doi.org/10.1016/j.regpep.2004.07.014openalex-snapshot
Glucagon-like peptide 1 and its derivatives in the treatment of diabetes
inferredcites →https://doi.org/10.1016/s0006-291x(02)00359-5openalex-snapshot
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective
inferredcites →https://doi.org/10.1016/s0006-2952(02)00996-6openalex-snapshot
Desensitization of insulin secretion
inferredcites →https://doi.org/10.1016/s0026-0495(98)90027-0openalex-snapshot
Nongenetic mouse models of non—insulin-dependent diabetes mellitus
inferredcites →https://doi.org/10.1016/s0092-8674(00)80709-6openalex-snapshot
Deconstructing Type 2 Diabetes
inferredcites →https://doi.org/10.1016/s0167-5699(99)01486-3openalex-snapshot
CD26, let it cut or cut it down
inferredcites →https://doi.org/10.1016/s0889-8529(05)70264-4openalex-snapshot
SULFONYLUREAS
inferredcites →https://doi.org/10.1021/jm030091lopenalex-snapshot
1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties
inferredcites →https://doi.org/10.1021/jm0493156openalex-snapshot
(2 R )-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- a ]pyrazin- 7(8 H )-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
inferredcites →https://doi.org/10.1038/414788aopenalex-snapshot
Diabetes mellitus and genetically programmed defects in β-cell function
inferredcites →https://doi.org/10.1073/pnas.0631828100openalex-snapshot
Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
inferredcites →https://doi.org/10.1073/pnas.120069197openalex-snapshot
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
inferredcites →https://doi.org/10.1074/jbc.271.38.23222openalex-snapshot
Investigation of Glucose-dependent Insulinotropic Polypeptide(1-42) and Glucagon-like Peptide-1-(7-36) Degradation by Dipeptidyl Peptidase IV Using Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry
inferredcites →https://doi.org/10.1074/jbc.m103106200openalex-snapshot
Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family
inferredcites →https://doi.org/10.1074/jbc.m212355200openalex-snapshot
The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides
inferredcites →https://doi.org/10.1074/jbc.m307972200openalex-snapshot
Overexpression of Repressive cAMP Response Element Modulators in High Glucose and Fatty Acid-treated Rat Islets
inferredcites →https://doi.org/10.1139/o59-099openalex-snapshot
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
inferredcites →https://doi.org/10.1172/jci116297openalex-snapshot
Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice.
inferredcites →https://doi.org/10.1172/jci117042openalex-snapshot
Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.
inferredcites →https://doi.org/10.1210/en.2002-0068openalex-snapshot
Glucose-Dependent Insulinotropic Polypeptide Promotes β-(INS-1) Cell Survival via Cyclic Adenosine Monophosphate-Mediated Caspase-3 Inhibition and Regulation of p38 Mitogen-Activated Protein Kinase
inferredcites →https://doi.org/10.1210/en.2002-220405openalex-snapshot
Glucagon-Like Peptide-1 Promotes Islet Cell Growth and Inhibits Apoptosis in Zucker Diabetic Rats
inferredcites →https://doi.org/10.1210/en.2004-1174openalex-snapshot
Inhibition of Dipeptidyl Peptidase-4 Augments Insulin Secretion in Response to Exogenously Administered Glucagon-Like Peptide-1, Glucose-Dependent Insulinotropic Polypeptide, Pituitary Adenylate Cyclase-Activating Polypeptide, and Gastrin-Releasing Peptide in Mice
inferredcites →https://doi.org/10.1210/jc.2002-020735openalex-snapshot
Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea
inferredcites →https://doi.org/10.1517/13543784.12.1.87openalex-snapshot
Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
inferredcites →https://doi.org/10.1677/joe.0.1740233openalex-snapshot
Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells
inferredcites →https://doi.org/10.2165/00024677-200201020-00005openalex-snapshot
Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1
inferredcites →https://doi.org/10.2174/092986730611220401163238openalex-snapshot
Glucagon-like Peptide-1, A Gastrointestinal Hormone with a Pharmaceutical Potential
inferredcites →https://doi.org/10.2337/diab.16.1.35openalex-snapshot
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
inferredcites →https://doi.org/10.2337/diab.40.2.166openalex-snapshot
β-cells in type II diabetes mellitus
inferredcites →https://doi.org/10.2337/diab.44.8.863openalex-snapshot
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
inferredcites →https://doi.org/10.2337/diabetes.40.2.166openalex-snapshot
Banting lecture 1990. Beta-cells in type II diabetes mellitus
inferredcites →https://doi.org/10.2337/diabetes.47.3.358openalex-snapshot
Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
inferredcites →https://doi.org/10.2337/diabetes.48.12.2270openalex-snapshot
Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.
inferredcites →https://doi.org/10.2337/diabetes.49.5.741openalex-snapshot
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.
inferredcites →https://doi.org/10.2337/diabetes.51.4.943openalex-snapshot
Long-Term Treatment With the Dipeptidyl Peptidase IV Inhibitor P32/98 Causes Sustained Improvements in Glucose Tolerance, Insulin Sensitivity, Hyperinsulinemia, and β-Cell Glucose Responsiveness in VDF (fa/fa) Zucker Rats
inferredcites →https://doi.org/10.2337/diabetes.51.5.1437openalex-snapshot
Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets
inferredcites →https://doi.org/10.2337/diabetes.51.5.1443openalex-snapshot
Persistent Improvement of Type 2 Diabetes in the Goto-Kakizaki Rat Model by Expansion of the β-Cell Mass During the Prediabetic Period With Glucagon-Like Peptide-1 or Exendin-4
inferredcites →https://doi.org/10.2337/diabetes.51.5.1461openalex-snapshot
Chronic Inhibition of Circulating Dipeptidyl Peptidase IV by FE 999011 Delays the Occurrence of Diabetes in Male Zucker Diabetic Fatty Rats
inferredcites →https://doi.org/10.2337/diabetes.52.3.741openalex-snapshot
Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats
inferredcites →https://doi.org/10.2337/diabetes.52.9.2304openalex-snapshot
Increased β-Cell Apoptosis Prevents Adaptive Increase in β-Cell Mass in Mouse Model of Type 2 Diabetes
inferredcites →https://doi.org/10.2337/diabetes.53.5.1326openalex-snapshot
Double Incretin Receptor Knockout (DIRKO) Mice Reveal an Essential Role for the Enteroinsular Axis in Transducing the Glucoregulatory Actions of DPP-IV Inhibitors
inferredcites →https://doi.org/10.2337/diacare.25.5.869openalex-snapshot
Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes
inferredcites →https://doi.org/10.7326/0003-4819-131-4-199908170-00008openalex-snapshot
Pharmacologic Therapy for Type 2 Diabetes Mellitus

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4903215openalex-extracted
SIRT3-Mediated Mitophagy Ameliorates Atherosclerosis by Attenuating Endothelial LDL Transcytosis in Diabetes
inferred← citeshttps://doi.org/10.1002/0471266949.bmc183openalex-snapshot
Dipeptidyl Peptidase 4 Inhibitors
inferred← citeshttps://doi.org/10.1002/0471266949.bmc183.pub2openalex-snapshot
Dipeptidyl Peptidase 4 Inhibitors
inferred← citeshttps://doi.org/10.1002/0471266949.bmc263openalex-snapshot
Translational Pharmaceutics and Early Phase Clinical Development
inferred← citeshttps://doi.org/10.1002/9780470910016.ch12openalex-snapshot
Dipeptidyl Peptidase IV Inhibitors for Treatment of Diabetes
inferred← citeshttps://doi.org/10.1002/9781118924853.ch12openalex-snapshot
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
inferred← citeshttps://doi.org/10.1002/9781119697473.ch16openalex-snapshot
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
inferred← citeshttps://doi.org/10.1002/dmrr.1101openalex-snapshot
Asiatic acid preserves beta cell mass and mitigates hyperglycemia in streptozocin‐induced diabetic rats
inferred← citeshttps://doi.org/10.1002/dmrr.2530openalex-snapshot
The New insights from DPP‐4 inhibitors: their potential immune modulatory function in autoimmune diabetes
inferred← citeshttps://doi.org/10.1002/dmrr.2981openalex-snapshot
When metformin is not enough: Pros and cons of SGLT2 and DPP‐4 inhibitors as a second line therapy
inferred← citeshttps://doi.org/10.1002/dmrr.720openalex-snapshot
Current literature in diabetes
inferred← citeshttps://doi.org/10.1002/jsfa.7041openalex-snapshot
Maternal exposure to diets containing flaxseed flour or flaxseed oil during pregnancy and lactation protects the aortic remodeling in adult male offspring of diabetic rat dams
inferred← citeshttps://doi.org/10.1002/pds.70277openalex-snapshot
Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/978-0-387-69737-6_12openalex-snapshot
The Incretin Modulators – Incretin Mimetics (GLP-1 Receptor Agonists) and Incretin Enhancers (DPP-4 Inhibitors)
inferred← citeshttps://doi.org/10.1007/978-1-4939-1399-2_2openalex-snapshot
Discovery Formulations: Approaches and Practices in Early Preclinical Development
inferred← citeshttps://doi.org/10.1007/978-1-60327-256-8_3openalex-snapshot
β-Cell Growth Mechanisms
inferred← citeshttps://doi.org/10.1007/978-1-62703-095-3_21openalex-snapshot
Using Diet to Induce Metabolic Disease in Rodents
inferred← citeshttps://doi.org/10.1007/978-4-431-75452-7_17openalex-snapshot
Incretins and Regulation of Insulin Secretion
inferred← citeshttps://doi.org/10.1007/978-90-481-3271-3_15openalex-snapshot
The Novel Roles of Glucagon-Like Peptide-1, Angiotensin II, and Vitamin D in Islet Function
inferred← citeshttps://doi.org/10.1007/978-90-481-3271-3_26openalex-snapshot
Prevention of β-Cell Destruction in Autoimmune Diabetes: Current Approaches and Future Prospects
inferred← citeshttps://doi.org/10.1007/978-94-007-6686-0_19openalex-snapshot
Current Approaches and Future Prospects for the Prevention of β-Cell Destruction in Autoimmune Diabetes
inferred← citeshttps://doi.org/10.1007/978-94-007-6884-0_19-2openalex-snapshot
Current Approaches and Future Prospects for the Prevention of β-Cell Destruction in Autoimmune Diabetes
inferred← citeshttps://doi.org/10.1007/s00108-007-1999-2openalex-snapshot
Neue orale Antidiabetika
inferred← citeshttps://doi.org/10.1007/s00125-006-0416-zopenalex-snapshot
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1007/s00125-009-1258-2openalex-snapshot
Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet
inferred← citeshttps://doi.org/10.1007/s00125-009-1390-zopenalex-snapshot
Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice
inferred← citeshttps://doi.org/10.1007/s00125-011-2217-2openalex-snapshot
Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice
inferred← citeshttps://doi.org/10.1007/s00125-011-2365-4openalex-snapshot
Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice
inferred← citeshttps://doi.org/10.1007/s00125-012-2582-5openalex-snapshot
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe −/− mice
inferred← citeshttps://doi.org/10.1007/s00125-012-2609-yopenalex-snapshot
A new view of the beta cell
inferred← citeshttps://doi.org/10.1007/s00125-012-2723-xopenalex-snapshot
Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition
inferred← citeshttps://doi.org/10.1007/s00125-012-2776-xopenalex-snapshot
Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes
inferred← citeshttps://doi.org/10.1007/s00125-013-2927-8openalex-snapshot
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model
inferred← citeshttps://doi.org/10.1007/s00210-008-0348-xopenalex-snapshot
Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA1c level, glucose intolerance, and lipid parameter level in streptozotocin–nicotinamide-induced diabetic mice
inferred← citeshttps://doi.org/10.1007/s00228-016-2175-1openalex-snapshot
The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1007/s10238-018-0519-0openalex-snapshot
Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes
inferred← citeshttps://doi.org/10.1007/s11596-022-2573-9openalex-snapshot
Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice
inferred← citeshttps://doi.org/10.1007/s11892-011-0179-xopenalex-snapshot
Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
inferred← citeshttps://doi.org/10.1007/s11914-020-00619-xopenalex-snapshot
Osteocyte Cellular Senescence
inferred← citeshttps://doi.org/10.1007/s12010-023-04619-2openalex-snapshot
Improving Biohydrogen Production by Dark Fermentation of Milk Processing Wastewater by Physicochemical and Enzymatic Pretreatments
inferred← citeshttps://doi.org/10.1007/s12015-021-10285-wopenalex-snapshot
Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine – Review
inferred← citeshttps://doi.org/10.1007/s12020-016-1073-8openalex-snapshot
DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation
inferred← citeshttps://doi.org/10.1007/s12272-016-0813-xopenalex-snapshot
DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
inferred← citeshttps://doi.org/10.1007/s12325-008-0076-1openalex-snapshot
DPP4 Inhibitors: a new approach in diabetes treatment
inferred← citeshttps://doi.org/10.1007/s12467-012-0002-6openalex-snapshot
On- en off-targeteffecten van dipeptidyl peptidase-4-remmers
inferred← citeshttps://doi.org/10.1007/s13300-018-0541-yopenalex-snapshot
Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis
inferred← citeshttps://doi.org/10.1007/s13340-017-0340-0openalex-snapshot
Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12443-6openalex-snapshot
DPP-4 Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-411508-8.00010-4openalex-snapshot
Translational Medicine and Biomarkers
inferred← citeshttps://doi.org/10.1016/b978-0-12-800093-9.00028-4openalex-snapshot
Bioactive Compounds Increase Incretins with Beneficial Effects on Diabetes
inferred← citeshttps://doi.org/10.1016/b978-0-12-800174-5.00008-9openalex-snapshot
Modulation of the Pancreatic Islet-Stress Axis as a Novel Potential Therapeutic Target in Diabetes Mellitus
inferred← citeshttps://doi.org/10.1016/b978-0-12-817214-8.00011-7openalex-snapshot
Translational medicine and biomarkers
inferred← citeshttps://doi.org/10.1016/b978-0-12-820088-9.00008-1openalex-snapshot
Cellular senescence and other aging mechanisms in bone and muscle
inferred← citeshttps://doi.org/10.1016/b978-0-12-822514-1.00011-0openalex-snapshot
Osteoporosis and bone loss
inferred← citeshttps://doi.org/10.1016/b978-0-443-15793-6.00003-2openalex-snapshot
Endocrinology and metabolism
inferred← citeshttps://doi.org/10.1016/b978-0-443-27402-2.00019-xopenalex-snapshot
Medicinal chemistry and process development of the type 2 diabetes drug sitagliptin
inferred← citeshttps://doi.org/10.1016/j.amjmed.2010.11.002openalex-snapshot
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
inferred← citeshttps://doi.org/10.1016/j.ando.2012.09.002openalex-snapshot
New avenues for the pharmacological management of type 2 diabetes: An update
inferred← citeshttps://doi.org/10.1016/j.archoralbio.2012.09.015openalex-snapshot
Dipeptidyl peptidase IV inhibitor improves the salivary gland histology of spontaneously diabetic mice
inferred← citeshttps://doi.org/10.1016/j.arcmed.2013.03.004openalex-snapshot
Vildagliptin Ameliorates Oxidative Stress and Pancreatic Beta Cell Destruction in Type 1 Diabetic Rats
inferred← citeshttps://doi.org/10.1016/j.atherosclerosis.2016.04.001openalex-snapshot
Posttranslational modulation of FoxO1 contributes to cardiac remodeling in post-ischemic heart failure
inferred← citeshttps://doi.org/10.1016/j.bbrc.2011.07.119openalex-snapshot
DPP-4 inhibitor des-F-sitagliptin treatment increased insulin exocytosis from db/db mice β cells
inferred← citeshttps://doi.org/10.1016/j.bbrc.2017.04.021openalex-snapshot
RETRACTED: TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice
inferred← citeshttps://doi.org/10.1016/j.bbrc.2019.10.194openalex-snapshot
NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy
inferred← citeshttps://doi.org/10.1016/j.bcp.2008.07.025openalex-snapshot
Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets
inferred← citeshttps://doi.org/10.1016/j.bcp.2011.10.003openalex-snapshot
A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats
inferred← citeshttps://doi.org/10.1016/j.bcp.2011.11.028openalex-snapshot
DPP-4 inhibitors in the treatment of type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.beem.2007.07.005openalex-snapshot
DPP-4 inhibitors
inferred← citeshttps://doi.org/10.1016/j.beem.2009.03.002openalex-snapshot
Incretin-based therapy: how do incretin mimetics and DPP-4 inhibitors fit into treatment algorithms for type 2 diabetic patients?
inferred← citeshttps://doi.org/10.1016/j.beem.2009.03.003openalex-snapshot
Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin – diabetes control and potential adverse events
inferred← citeshttps://doi.org/10.1016/j.beem.2009.03.004openalex-snapshot
Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)
inferred← citeshttps://doi.org/10.1016/j.biochi.2014.12.005openalex-snapshot
RETRACTED: Combination of carvacrol and rosiglitazone ameliorates high fat diet induced changes in lipids and inflammatory markers in C57BL/6J mice
inferred← citeshttps://doi.org/10.1016/j.biomag.2013.05.006openalex-snapshot
Antihyperglycemic activity of trigonelline and sitagliptin in nicotinamide-streptozotocin induced diabetes in Wistar rats
inferred← citeshttps://doi.org/10.1016/j.bionut.2011.09.002openalex-snapshot
Flavonoid rich fraction of Pilea microphylla (L.) attenuates metabolic abnormalities and improves pancreatic function in C57BL/KsJ-db/db mice
inferred← citeshttps://doi.org/10.1016/j.bj.2020.10.002openalex-snapshot
Implanted islet mass influences the effects of dipeptidyl peptidase-IV inhibitor LAF237 on transplantation outcomes in diabetic mice
inferred← citeshttps://doi.org/10.1016/j.ccl.2008.06.008openalex-snapshot
Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review
inferred← citeshttps://doi.org/10.1016/j.cell.2017.01.040openalex-snapshot
Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes
inferred← citeshttps://doi.org/10.1016/j.celrep.2018.01.063openalex-snapshot
β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion
inferred← citeshttps://doi.org/10.1016/j.clinthera.2007.12.034openalex-snapshot
Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.clinthera.2010.06.004openalex-snapshot
Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects
inferred← citeshttps://doi.org/10.1016/j.clinthera.2011.04.024openalex-snapshot
Clinical Pharmacology of Incretin Therapies for Type 2 Diabetes Mellitus: Implications for Treatment
inferred← citeshttps://doi.org/10.1016/j.clinthera.2017.01.015openalex-snapshot
Effects of Oral Antidiabetic Drugs on Changes in the Liver-to-Spleen Ratio on Computed Tomography and Inflammatory Biomarkers in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.coph.2006.08.003openalex-snapshot
GLP-1 and type 2 diabetes: physiology and new clinical advances
inferred← citeshttps://doi.org/10.1016/j.curtheres.2016.12.002openalex-snapshot
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Atherosclerosis, β-Cell Function, and Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus Who are Treatment Naïve or Poorly Responsive to Antidiabetes Agents: A Multicenter, Prospective Observational,…
inferred← citeshttps://doi.org/10.1016/j.ddmod.2007.11.006openalex-snapshot
Models for pharmacological activation of beta-cell regeneration in diabetes
inferred← citeshttps://doi.org/10.1016/j.diabres.2006.08.015openalex-snapshot
β-Cell preservation with thiazolidinediones
inferred← citeshttps://doi.org/10.1016/j.diabres.2010.10.012openalex-snapshot
A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis
inferred← citeshttps://doi.org/10.1016/j.diabres.2011.01.016openalex-snapshot
Effect of sitagliptin plus metformin on β-cell function, islet integrity and islet gene expression in Zucker diabetic fatty rats
inferred← citeshttps://doi.org/10.1016/j.diabres.2015.02.022openalex-snapshot
Saxagliptin is similar in glycaemic variability more effective in metabolic control than acarbose in aged type 2 diabetes inadequately controlled with metformin
inferred← citeshttps://doi.org/10.1016/j.diabres.2015.12.013openalex-snapshot
c-Abl contributes to glucose-promoted apoptosis via p53 signaling pathway in podocytes
inferred← citeshttps://doi.org/10.1016/j.drudis.2011.08.017openalex-snapshot
The potential of incretin-based therapies in type 1 diabetes
inferred← citeshttps://doi.org/10.1016/j.dsx.2013.06.009openalex-snapshot
One-year real-life efficacy of sitagliptin revealed importance of concomitant pioglitazone use in Japanese patients with type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.ejphar.2008.04.018openalex-snapshot
Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice
inferred← citeshttps://doi.org/10.1016/j.ejphar.2008.04.047openalex-snapshot
Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys
inferred← citeshttps://doi.org/10.1016/j.ejphar.2009.09.027openalex-snapshot
Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.ejphar.2010.10.062openalex-snapshot
The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats
inferred← citeshttps://doi.org/10.1016/j.ejphar.2012.07.030openalex-snapshot
Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats
inferred← citeshttps://doi.org/10.1016/j.ejphar.2012.09.024openalex-snapshot
A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations
inferred← citeshttps://doi.org/10.1016/j.ejphar.2015.11.029openalex-snapshot
Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.ejphar.2015.11.033openalex-snapshot
Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats
inferred← citeshttps://doi.org/10.1016/j.ejphar.2016.06.016openalex-snapshot
Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/j.ejphar.2016.11.042openalex-snapshot
Salicylic acid retention impairs aspirin reactivity in type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.ejphar.2019.172521openalex-snapshot
Contribution of intestinal dipeptidyl peptidase-4 inhibition for incretin-dependent improved glucose tolerance in mice
inferred← citeshttps://doi.org/10.1016/j.ejps.2012.07.012openalex-snapshot
16,17-Dihydro-17b-hydroxy isomitraphylline alkaloid as an inhibitor of DPP-IV, and its effect on incretin hormone and β-cell proliferation in diabetic rat
inferred← citeshttps://doi.org/10.1016/j.endmag.2008.04.014openalex-snapshot
10.1016/j.endmag.2008.04.014
inferred← citeshttps://doi.org/10.1016/j.endmts.2024.100174openalex-snapshot
The efficacy and safety of Diptptidyl peptidase-4 inhibitors combined with insulin in patients with autoimmune diabetes: A updated meta-analysis
inferred← citeshttps://doi.org/10.1016/j.etp.2010.12.009openalex-snapshot
Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice
inferred← citeshttps://doi.org/10.1016/j.fbio.2021.101434openalex-snapshot
Improvement of diabetes-induced metabolic syndrome by millet prolamin is associated with changes in serum metabolomics
inferred← citeshttps://doi.org/10.1016/j.fitote.2011.10.011openalex-snapshot
Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 Diabetes mice induced by High-Fat Diet combining with Streptozotocin via suppression of hepatic gluconeogenesis
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107518openalex-snapshot
Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes
inferred← citeshttps://doi.org/10.1016/j.jcf.2013.02.008openalex-snapshot
Update on cystic fibrosis-related diabetes
inferred← citeshttps://doi.org/10.1016/j.jchromb.2015.05.003openalex-snapshot
Application of GC/MS-based metabonomic profiling in studying the therapeutic effects of Huangbai–Zhimu herb-pair (HZ) extract on streptozotocin-induced type 2 diabetes in mice
inferred← citeshttps://doi.org/10.1016/j.jcyt.2013.05.005openalex-snapshot
Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis—evaluations in vitro and in the rat critical limb ischemia model
inferred← citeshttps://doi.org/10.1016/j.jfda.2018.12.009openalex-snapshot
Nelumbo nucifera leaves extract attenuate the pathological progression of diabetic nephropathy in high-fat diet-fed and streptozotocin-induced diabetic rats
inferred← citeshttps://doi.org/10.1016/j.jsps.2019.10.001openalex-snapshot
Effect of olive leaves extract on the antidiabetic effect of glyburide for possible herb-drug interaction
inferred← citeshttps://doi.org/10.1016/j.lfs.2019.116738openalex-snapshot
The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.120515openalex-snapshot
ZD-2, a novel DPP4 inhibitor, protects islet β-cell and improves glycemic control in high-fat-diet-induced obese mice
inferred← citeshttps://doi.org/10.1016/j.mad.2021.111565openalex-snapshot
The role of senolytics in osteoporosis and other skeletal pathologies
inferred← citeshttps://doi.org/10.1016/j.mce.2012.08.003openalex-snapshot
The molecular mechanisms of pancreatic β-cell glucotoxicity: Recent findings and future research directions
inferred← citeshttps://doi.org/10.1016/j.mce.2014.04.017openalex-snapshot
Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes
inferred← citeshttps://doi.org/10.1016/j.mce.2015.12.012openalex-snapshot
Repetitive exposure to low-dose X-irradiation attenuates testicular apoptosis in type 2 diabetic rats, likely via Akt-mediated Nrf2 activation
inferred← citeshttps://doi.org/10.1016/j.mehy.2013.11.002openalex-snapshot
Altered autonomic inputs as a cause of pancreatic β-cell amyloid
inferred← citeshttps://doi.org/10.1016/j.metabol.2013.01.010openalex-snapshot
Dipeptidyl peptidase-4 inhibitor anagliptin ameliorates diabetes in mice with haploinsufficiency of glucokinase on a high-fat diet
inferred← citeshttps://doi.org/10.1016/j.metabol.2019.154031openalex-snapshot
The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship
inferred← citeshttps://doi.org/10.1016/j.molmet.2016.07.003openalex-snapshot
Fibroblast activation protein (FAP) as a novel metabolic target
inferred← citeshttps://doi.org/10.1016/j.nbd.2012.07.025openalex-snapshot
Metabolic stress response implicated in diabetic retinopathy: The role of calpain, and the therapeutic impact of calpain inhibitor
inferred← citeshttps://doi.org/10.1016/j.nutres.2022.03.011openalex-snapshot
Lactoferrin improves hepatic insulin resistance and pancreatic dysfunction in high-fat diet and streptozotocin-induced diabetic mice
inferred← citeshttps://doi.org/10.1016/j.peptides.2011.03.003openalex-snapshot
An update on the islet renin–angiotensin system
inferred← citeshttps://doi.org/10.1016/j.pharep.2015.01.010openalex-snapshot
Immunohistochemical, apoptotic and biochemical changes by dipeptidyl peptidase-4 inhibitor-sitagliptin in type-2 diabetic rats
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2008.11.009openalex-snapshot
An update on preventive and regenerative therapies in diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2009.06.002openalex-snapshot
Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2009.11.001openalex-snapshot
Glycaemic control in type 2 diabetes: Targets and new therapies
inferred← citeshttps://doi.org/10.1016/j.phrs.2007.01.014openalex-snapshot
Preventive effects of fenofibrate on insulin resistance, hyperglycaemia, visceral fat accumulation in NIH mice induced by small-dose streptozotocin and lard
inferred← citeshttps://doi.org/10.1016/j.phrs.2016.09.029openalex-snapshot
Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs—A mechanistic revisit to understand their mode of action
inferred← citeshttps://doi.org/10.1016/j.phrs.2022.106086openalex-snapshot
CD74 ablation rescues type 2 diabetes mellitus-induced cardiac remodeling and contractile dysfunction through pyroptosis-evoked regulation of ferroptosis
inferred← citeshttps://doi.org/10.1016/j.phymed.2013.03.003openalex-snapshot
Anti-diabetic activity of embelin: Involvement of cellular inflammatory mediators, oxidative stress and other biomarkers
inferred← citeshttps://doi.org/10.1016/j.regpep.2009.12.005openalex-snapshot
Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus
inferred← citeshttps://doi.org/10.1016/j.taap.2015.10.019openalex-snapshot
Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway
inferred← citeshttps://doi.org/10.1016/j.tips.2008.02.001openalex-snapshot
Preservation of β-cell function by targeting β-cell mass
inferred← citeshttps://doi.org/10.1016/j.toxlet.2018.01.006openalex-snapshot
Diabetic cognitive dysfunction is associated with increased bile acids in liver and activation of bile acid signaling in intestine
inferred← citeshttps://doi.org/10.1016/j.transproceed.2011.02.059openalex-snapshot
Successful Long-Term Use of Sitagliptin for the Treatment of New-Onset Diabetes Mellitus After Solid Organ Transplantation: A Case Report
inferred← citeshttps://doi.org/10.1016/j.trsl.2010.05.004openalex-snapshot
The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats
inferred← citeshttps://doi.org/10.1016/j.trsl.2018.10.006openalex-snapshot
Small molecule inhibition of dipeptidyl peptidase-4 enhances bone marrow progenitor cell function and angiogenesis in diabetic wounds
inferred← citeshttps://doi.org/10.1016/j.vascn.2010.04.001openalex-snapshot
Reversibility of hyperglycaemia and islet abnormalities in the high fat-fed female ZDF rat model of type 2 diabetes
inferred← citeshttps://doi.org/10.1016/s0014-2565(10)70004-7openalex-snapshot
¿Qué ha cambiado en la estrategia terapéutica de la diabetes mellitus tipo 2?
inferred← citeshttps://doi.org/10.1016/s0065-7743(07)42007-3openalex-snapshot
Chapter 7 Case History: JANUVIA™ (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
inferred← citeshttps://doi.org/10.1016/s0084-3741(08)70009-xopenalex-snapshot
Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes
inferred← citeshttps://doi.org/10.1016/s0140-6736(06)69705-5openalex-snapshot
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
inferred← citeshttps://doi.org/10.1016/s0828-282x(10)70010-6openalex-snapshot
The incretin system and cardiometabolic disease
inferred← citeshttps://doi.org/10.1016/s1499-2671(08)22010-1openalex-snapshot
Incretin-based Therapies for Type 2 Diabetes
inferred← citeshttps://doi.org/10.1016/s1557-0843(09)80004-3openalex-snapshot
DPP-4 inhibitors
inferred← citeshttps://doi.org/10.1016/s1557-0843(09)80029-8openalex-snapshot
Appropriate, timely, and rational treatment of type 2 diabetes mellitus: Meeting the challenges of primary care
inferred← citeshttps://doi.org/10.1016/s1575-0922(08)76259-4openalex-snapshot
Sulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
inferred← citeshttps://doi.org/10.1016/s1957-2557(08)70425-5openalex-snapshot
La sitagliptine, inhibiteur de la DPP-IV : un nouvel anti-diabétique oral
inferred← citeshttps://doi.org/10.1017/jns.2019.40openalex-snapshot
Ficus deltoidea extract down-regulates protein tyrosine phosphatase 1B expression in a rat model of type 2 diabetes mellitus: a new insight into its antidiabetic mechanism
inferred← citeshttps://doi.org/10.1021/acs.jafc.7b02880openalex-snapshot
Caffeic Acid Phenethyl Ester (Propolis Extract) Ameliorates Insulin Resistance by Inhibiting JNK and NF-κB Inflammatory Pathways in Diabetic Mice and HepG2 Cell Models
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00374openalex-snapshot
Design, Synthesis, and Evaluation of a Series of Novel Super Long-Acting DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.8b00305openalex-snapshot
Discovery and Pharmacology of a Novel Somatostatin Subtype 5 (SSTR5) Antagonist: Synergy with DPP-4 Inhibition
inferred← citeshttps://doi.org/10.1021/jm900367wopenalex-snapshot
Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia
inferred← citeshttps://doi.org/10.1021/jm901893xopenalex-snapshot
(1 S )-1,5-Anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio- d -glucitol (TS-071) is a Potent, Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for Type 2 Diabetes Treatment
inferred← citeshttps://doi.org/10.1038/aps.2012.75openalex-snapshot
Acute and chronic administration of SHR117887, a novel and specific dipeptidyl peptidase-4 inhibitor, improves metabolic control in diabetic rodent models
inferred← citeshttps://doi.org/10.1038/ki.2013.113openalex-snapshot
NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy
inferred← citeshttps://doi.org/10.1038/s41401-018-0016-8openalex-snapshot
Repurposing matrine for the treatment of hepatosteatosis and associated disorders in glucose homeostasis in mice
inferred← citeshttps://doi.org/10.1038/s41467-022-28561-9openalex-snapshot
Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists
inferred← citeshttps://doi.org/10.1038/s41467-023-36680-0openalex-snapshot
THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic β-cell function and preserving β-cell mass
inferred← citeshttps://doi.org/10.1038/s41598-017-06731-wopenalex-snapshot
The Role of Inflammation in β-cell Dedifferentiation
inferred← citeshttps://doi.org/10.1038/s41598-017-08319-wopenalex-snapshot
TonEBP/NFAT5 haploinsufficiency attenuates hippocampal inflammation in high-fat diet/streptozotocin-induced diabetic mice
inferred← citeshttps://doi.org/10.1038/s41598-021-94896-wopenalex-snapshot
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
inferred← citeshttps://doi.org/10.1038/sj.clpt.6100167openalex-snapshot
Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Focus On Sitagliptin
inferred← citeshttps://doi.org/10.1038/srep12348openalex-snapshot
Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation
inferred← citeshttps://doi.org/10.1038/srep35640openalex-snapshot
Recombinant Reg3β protein protects against streptozotocin-induced β-cell damage and diabetes
inferred← citeshttps://doi.org/10.1038/srep44865openalex-snapshot
Effects of dipeptidyl peptidase-4 inhibitors on beta-cell function and insulin resistance in type 2 diabetes: meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1039/c2fo30199gopenalex-snapshot
Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function
inferred← citeshttps://doi.org/10.1039/c4fo00430bopenalex-snapshot
Hypoglycemic, hypolipidemic and antioxidant effects of Sarcandra glabra polysaccharide in type 2 diabetic mice
inferred← citeshttps://doi.org/10.1039/c4fo00859fopenalex-snapshot
Angelica sinensis polysaccharide regulates glucose and lipid metabolism disorder in prediabetic and streptozotocin-induced diabetic mice through the elevation of glycogen levels and reduction of inflammatory factors
inferred← citeshttps://doi.org/10.1042/bsr20170665openalex-snapshot
Chemoprotective effects of butanol fraction of Buchholzia coriacea (Capparidaceae) against type 2 diabetes and oxidative stress in male Wistar rats
inferred← citeshttps://doi.org/10.1042/cs20100372openalex-snapshot
Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats
inferred← citeshttps://doi.org/10.1053/j.gastro.2007.03.054openalex-snapshot
Biology of Incretins: GLP-1 and GIP
inferred← citeshttps://doi.org/10.1053/j.gastro.2009.09.004openalex-snapshot
Differential Importance of Glucose-Dependent Insulinotropic Polypeptide vs Glucagon-Like Peptide 1 Receptor Signaling for Beta Cell Survival in Mice
inferred← citeshttps://doi.org/10.1053/j.gastro.2009.10.013openalex-snapshot
The Incretins and β-Cell Health: Contrasting Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 as a Path to Understand Islet Function in Diabetes
inferred← citeshttps://doi.org/10.1074/jbc.m110.217216openalex-snapshot
Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased β Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes
inferred← citeshttps://doi.org/10.1074/jbc.m114.615484openalex-snapshot
Mouse Insulin Cells Expressing an Inducible RIPCre Transgene Are Functionally Impaired
inferred← citeshttps://doi.org/10.1074/jbc.m609637200openalex-snapshot
Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells
inferred← citeshttps://doi.org/10.1080/00325481.2016.1191955openalex-snapshot
Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy’s safety profile
inferred← citeshttps://doi.org/10.1080/14656566.2016.1241235openalex-snapshot
New fixed dose chemical combinations: the way forward for better diabetes type II management?
inferred← citeshttps://doi.org/10.1080/14786419.2022.2113875openalex-snapshot
Bauhinia forficata link extract attenuates insulin resistance by preserving glucose uptake in gastrocnemius muscle
inferred← citeshttps://doi.org/10.1080/21623945.2020.1721970openalex-snapshot
Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4
inferred← citeshttps://doi.org/10.1089/jmf.2020.4717openalex-snapshot
Polysaccharides from the Fleshy Fruits of Camellia oleifera Attenuate the Kidney Injury in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
inferred← citeshttps://doi.org/10.1089/met.2012.0128openalex-snapshot
Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats
inferred← citeshttps://doi.org/10.1093/ndt/gfs583openalex-snapshot
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
inferred← citeshttps://doi.org/10.1097/maj.0b013e31818eb721openalex-snapshot
Impact of Sitagliptin on Markers of β-cell Function: A Meta-Analysis
inferred← citeshttps://doi.org/10.1097/mcp.0b013e32833e8700openalex-snapshot
Update on cystic fibrosis-related diabetes
inferred← citeshttps://doi.org/10.1097/med.0b013e3280a02f65openalex-snapshot
Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1097/med.0b013e3280d5f7e9openalex-snapshot
Current World Literature
inferred← citeshttps://doi.org/10.1097/med.0b013e3282c3a898openalex-snapshot
Current World Literature
inferred← citeshttps://doi.org/10.1097/mjt.0b013e3180ed42dcopenalex-snapshot
Therapeutic Potential of Dipeptidyl Peptidase-IV Inhibitors in Patients With Diabetes Mellitus
inferred← citeshttps://doi.org/10.1097/mpa.0000000000001039openalex-snapshot
Functional Correlation Between the Pancreas and the Small Intestine in Humans
inferred← citeshttps://doi.org/10.1097/mpa.0b013e318214832dopenalex-snapshot
Improved Outcome of Islet Transplantation in Partially Pancreatectomized Diabetic Mice by Inhibition of Dipeptidyl Peptidase-4 With Sitagliptin
inferred← citeshttps://doi.org/10.1101/2021.04.16.440207openalex-snapshot
Focused Ultrasound Modulation of Hepatic Neural Plexus Restores Glucose Homeostasis in Diabetes
inferred← citeshttps://doi.org/10.1107/s1600536809050624openalex-snapshot
(R)-1-[(S)-(3-Cyanothiomorpholino)carbonyl]-2-methylpropylaminium chloride dihydrate
showing the first 200 of 432 · page through all 432
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.